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Abstract 
 Smoking and diabetes could both be 
prevented if individuals would abstain from smoking, 
eat healthy, and exercise regularly. Smokers with 
diabetes have an increased risk of serious health 
outcomes, hence effective smoking cessation 
interventions are critical. The transtheoretical model 
was used in this quantitative study analyzing 
secondary data from the state of Nevada Quitline to 
examine the relationships between smoking cessation 
method (counseling versus counseling and 
medication) and quitting smoking for 720 smokers 
with/without diabetes. Participants were Nevada 
residents, ages 18+, men and women, English or 
Spanish speakers. Descriptive statistics, logistic 
regression, and a test of two proportions were 
conducted. The majority of the participants had not 
quit (67.5%). Quit rates did not differ between 
smokers with/without diabetes, however, individuals 
who received counseling and medication were 1.94 
times as likely to quit compared to those who 
received counseling alone. Among diabetes smokers, 
age was significantly related to quit status; for every 
1 year, the likelihood of quitting increased by 1.03 
times; and Hispanics were 7.50 times more likely to 
quit smoking compared to Caucasians. Findings from 
this study could help healthcare providers, public 
health practitioners, and scholars develop effective 
smoking cessation programs to meet the needs of 
smokers with diabetes.  
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Smoking, diabetes, Nevada, interventions. 
 
Introduction 
 
Smoking is one of the most preventable 
causes of disease and premature death in the United 
States, killing 480,000 people each year (Centers for 
Disease and Prevention [CDC], 2012a; U. S. 
Department of Health and Human Resources, 
[USDHHS], 2014). While it could be prevented, 
diabetes, is the seventh leading cause of death in the 
United States that results in long term chronic disease 
consequences (CDC, 2014b). Smokers with diabetes 
are said to be less active compared to smokers 
without diabetes (Tonstand, 2009; Solberg, Desai, 
O'Connor, Bishop, & Devlin, 2004). The prevalence 
of smoking as well as that of diabetes is expected to 
grow within the next two decades (Will et al., 2007). 
As of 2010, diabetes has been reported to affect 25.8 
million people or 8.3% of the U.S. population (CDC, 
2011c). By the year 2030, tobacco dependence will 
be the cause of 8 million deaths, directly or indirectly 
(World Health Organization [WHO], 2012). 
According to the CDC, over 100 million people have 
died as a result of tobacco use during the 20th century 
and an estimate of 1 billion people could be killed in 
the 21st century (CDC, 2011d).  
 
In this study, the researchers examined quit 
rates among smokers with diabetes in comparison to 
those without diabetes and identified the most 
effective smoking cessation method utilized by the 
study population. This study intends to promote 
positive social change by helping healthcare 
providers, public health practitioners, and scholars 
develop effective smoking cessation programs for 
smokers with and without diabetes. According to the 
American Chemical Society ([ACS], 2011), smokers 
with diabetes have a higher level of hemoglobin A1c 
(HbA1c), which is the gold standard for monitoring 
long-term blood sugar levels in people with diabetes. 
Therefore, people with diabetes may respond 
differently to smoking cessation programs from 
people without diabetes; both genetically and 
psychologically (ACS, 2011). Psychologically, those 
who developed diabetes as a result of their smoking 
may be more likely to quit due to more serious 
consequences from smoking than others.  
 
 The number of individuals with diabetes 
continues to grow as a result of the increase in 
population, urbanization, aging, and other risk factors 
such as obesity and lack of physical activities (Wild, 
Roglic, Green, Sicree, & King, 2004). Smokers with 
diabetes are less motivated to quit when compared to 
the general population (Selby, 2008) and many times 
this group of individuals lacks the knowledge, 
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awareness, and understanding of smoking cessation 
options such as counseling and medications (Gill, 
2005). Sherman (2005) recommended that clinicians 
should identify and provide combination therapy (i.e., 
counseling and medication) options to smokers with 
diabetes. The goal of this study was to: (a). compare 
quit rates among smokers with or without diabetes 
and (b). identify the most effective smoking cessation 
method utilized by smokers with or without diabetes. 
The potential positive social change aspect of this 
study is that it may provide smokers with diabetes as 
well as healthcare professionals with information 
about effective smoking cessation methods, 
specifically concerning what role counseling alone or 
a combination of counseling and medication plays in 
helping individuals quit. If they quit, smokers with 
diabetes will reduce the risk for heart attack, stroke, 
nerve damage, and kidney damage while their blood 
pressure, blood circulation, and blood cholesterol 
could improve (Selby, 2008; Sherman, 2005; 
Steinberg et al., 2008). 
 
Purpose of the Study 
The purpose of this study is to investigate 
(a) quit rates among smokers with diabetes compared 
to smokers without diabetes (b) the association 
between quitting smoking and the type of smoking 
cessation method used. This quantitative study used 
secondary data from the state of Nevada Quitline 
(also known as the Nevada Tobacco Users Helpline 
[NTUH]) that was previously collected for 
counseling and treatment services. The study 
described and compared the effectiveness of each 
method (e.g., counseling alone [Level II] or a 
combination of counseling and medications [Level 
III]). The dependent variable was quit status during 
the last follow up. The independent variables were: 
counseling and a combination of counseling and 
medications used.  
 
Theoretical Foundation 
This research project tested the effectiveness 
of counseling, and a combination of counseling and 
medications. The transtheoretical model (TTM) was 
used. This model presents five stages that are: 
precontemplation, contemplation, preparation, action, 
and maintenance (Prochaska & Goldstein, 1991). 
TTM is useful for identifying positive social change 
and a stage that an individual is in the change process 
(Zimmerman, Olsen, & Bosworth, 2000). Also, TTM 
allows programs to monitor interventions and provide 
constructive feedback that will prevent the subjects 
from rushing through the process or moving too slow. 
Using the TTM stage-matched, patient-centered 
approach can help physicians as well as healthcare 
professionals design more effective treatment or 
counseling interventions, which reduces treatment 
resistance and increase treatment compliance 
(Martin, Williams, Haskard, & Di Matteo, 2005; 
Prochaska & Goldstein, 1991).   
 
Counseling 
For many years, diabetes patients continue 
to smoke despite its negative impact on their health. 
Diabetes is registered next to other co-morbid health 
conditions as a target factor for smoking cessation 
treatment as a result of greater risks connected with 
this disease and smoking (Tonstand, 2009). The 
prevalence of smoking is almost the same among 
those with diabetes (27.4%) and those without 
diabetes (25.9%; American Diabetes Association 
[ADA], 2004; Haire-Joshu et al., 1999; Sherman, 
2005; Tonstand, 2009). Most cigarette smokers want 
to quit; however, it is hard for them without proper 
support and understanding of the existing options that 
they have (Steinberg et al., 2008). The role of 
counseling is important when it comes to smoking 
cessation as cigarette smoking may result in poor 
health outcomes especially for persons with diabetes 
(Canga et al. 2000; Selby 2008). Therefore, 
counseling is thought to be one of the most effective 
public health interventions when it comes to smoking 
cessation and prevention efforts and this intervention 
approach has made a difference in the lives of many 
smokers (Selby, 2008).  
 
Medication 
Smoking cessation medications increase the 
odds of successful quitting as compared to non-
medication cessation efforts (Selby, 2008). The first 
seven recommended medications that increase the 
chances of long-term abstinence rates are: Nicotine 
gum, Bupropion, Nicotine lozenge, Nicotine inhaler, 
Nicotine patch, Nicotine nasal spray, and Varenicline 
(CDC, n.d; Fiore, Bailey, Cohen, Dorfman, 
Goldstein, & Gritz, 2008; Steinberg, et al., 2008; 
Tonstand, 2009). A combination of medications is 
also recommended just as counseling and medication 
is recommended over either method alone (CDC, 
n.d.; Selby, 2008; Sherman, 2005; Steinberg, et al., 
2008). A combination of lozenges and gum is 
recommended for smokers with diabetes for a period 
of up to 12 weeks (Tonstand, 2009). There is limited 
data pertaining to the effectiveness of smoking 
cessation medications among persons with diabetes 
(Tonstand, 2009). Many times smokers with diabetes 
have poor performance in terms of knowledge, 
awareness, and understanding of smoking cessation 
medications (Gill, Morgan, & MacFarlane, 2005). 
The state of Nevada Quitline uses over the counter 
medications: Gum, Lozenge, and Patches for light 
smokers (those who smoke less than 20 cigarettes per 
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day), and prescription medication: Nicotine inhaler, 
Bupropion, and Varenicline for heavy smokers (those 
who smoke a pack a day or higher; NTUH, n.d.). For 
light smokers who were in the contemplation or pre-
contemplation stage of change, without a projected 
quit date or with a projected quit date farther than 90 
days, were recommended counseling and over the 
counter medications. For heavy smokers who were in 
the preparation stage of change, with a projected quit 
date within the next 90 days, were recommended 
counseling and prescription medications.  
 
Methods 
Data Collection 
This study used secondary data from the 
state of Nevada Quitline that was previously 
collected for service purposes from January 1, 2010 
to September 1, 2011 for intake and from July 1, 
2010 to March 1, 2012 for the 6 months evaluation 
follow-up. The data used were a portion of a larger 
dataset of 3,500 quitline callers. However, when data 
was cleaned and tested, the final sample size for this 
research study was 720 callers, of which 613 had 
completed every question used for this study. Using a 
quasi-experimental study design, this study 
controlled the assignment to the treatment groups by 
separating the data for those who received counseling 
only (Level II) versus those who received a 
combination of counseling and medication (Level 
III).     
 
Data was retrieved after an Institutional 
Review Board (IRB) approval from Walden 
University (#08-14-13-0137985). No identifying 
information was gathered. The data collection 
instrument consisted of intake information and 
evaluation follow-up questions at 6 months. Ethical 
guidelines were followed that included: respect of 
human subject rights, understanding of their needs, 
values, and their desire to participate in the study 
(Creswell, 2009, p.198). In order to guarantee the 
highest level of confidentiality, all Quitline data 
collected is protected under confidentiality laws, 
including the Health Insurance Portability and 
Accountability Act of 1996 (HIPAA) and the Nevada 
Revised Statues (NRS). All data collected from 
Quitline callers is stored in a secured web application 
(NTUH, n.d.).  
 
Eligibility 
 The sample population consisted of Nevada 
residents, ages 18 years and older, men and women, 
English or Spanish speakers, who were enrolled 
during the study time frame for free smoking 
cessation services from the state of Nevada Quitline 
program. Participants had to be current or discharged 
smokers (those who have quit and completed the 
program) who received Level II or Level III free 
Quitline services during the time of their enrollment. 
Since the Quitline provides services in English and 
Spanish languages, data from study participants who 
spoke either or both of the two languages were 
included. 
 
Analysis 
 We used SPSS 22.0 statistical package for 
data analysis, including descriptive statistics, logistic 
regression, and a test of two proportions in order to 
answer the research questions. The p-value 
significance level was set at 0.05 and all values that 
were equal to or less than 0.05 were considered as 
statistically significant. Specifically, the dependent 
variable is quit status at last follow up and the 
independent variables are the types of smoking 
cessation methods utilized. Additional descriptive 
variables are also included. The following steps were 
used: data preparation, descriptive statistics, and 
statistical analyses - as recommended by Trochim 
and Donnelly (2008, p. 252). Finally, statistical 
analyses of logistic regression, and the test of two 
proportions were done in order to test hypotheses and 
find answers to the research questions.  
 
Results 
 
Descriptive Statistics 
The frequencies and percentages for the 
categorical demographic variables are displayed in 
Table  - Appendix A. More participants were female 
(56.8%) than were male (43.2%). The majority of the 
participants were Caucasian (66.1%), followed by 
African American (15.8%), and Hispanics (14.4%). 
Most of the participants intended to quit smoking 
within 30 days (94.1%). Only 15.1% of participants 
reported calling due to the advice of a physician. 
Approximately 60% of participants received 
counseling only (61.1%) compared to 38.9% who 
received both counseling and medication. Finally, 
16.9% of participants reported having diabetes. The 
mean age was 47.69 years (SD = 13.48) with a 
minimum of 18 years and a maximum of 83 years.  
 
Dependent Variables 
The majority of the study participants 
indicated "no" to Quitting (67.5%) as compared to 
those who indicated "Yes" to Quitting (32.5%).  
 
Research Question 1 
Crosstab analyses using Pearson’s chi-
square and Cramer’s V tests were conducted to 
examine the relationships between diabetes and quit 
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status. The relationship between quit status and 
diabetes was not significant, p = .618. The proportion 
of those with diabetes who had quit was 34.4%, 
which was not significantly different than the 32.1% 
of those without diabetes who quit. 
 
Research Question 2 
A logistic regression analysis was conducted 
to predict quit status from the type of smoking 
cessation method used, diabetes status, and 
covariates, Table 2- Appendix B. Level of service and 
diabetes status was entered as block 1 and the other 
demographics were added as block 2. Overall, block 
1 was significant, p < .001, Nagelkerke R2 = .035. 
Level of service was a significant predictor, p < .001, 
and had a significant odds ratio of 2.015 indicating 
that those who got counseling and medication were 
about twice as likely to quit compared to those who 
got counseling only. Although overall block 2 was 
significant with level of service, diabetes, and the 
covariates, p = .021, Nagelkerke R2 = .047, the model 
change was not statistically significant, p = .819, 
Nagelkerke R2 = .012.  
 
When the predictors in block 2 were 
examined solely for the purpose of better 
understanding the model, level of service was still a 
significant predictor, p < .001, and had an odds ratio 
of 1.94. This is very similar to the odds ratio revealed 
in block 1. In addition, none of the remaining 
predictors (e.g., age, ethnicity, physician advice, or 
the readiness to quit assessment questions) were 
significant predictors of quit status (ps > .05) 
providing further evidence that block 1 should be 
used to evaluate hypotheses 2. 
 
Discussion 
 
 The relationship between quit status and 
diabetes was not significant and this implies that quit 
rates were not any different between smokers with 
diabetes versus smokers without diabetes. These 
findings are supported by the literature whereby 
Schauer et al. (2008) and Sherman (2005) reported 
that there were no major differences when it comes to 
quit rates for those with and without diabetes. The 
level of service that smokers received was a 
significant predictor of quit status, indicating that 
those who got counseling and medication were about 
twice as likely to quit compared to those who got 
counseling only. Even though many variables were 
included into the model, the explained variance in 
quitting was minimal at 3.5 to 4.7%. This model 
explains very little of the variance in quitting because 
there are other factors at work and also because the 
quit rates were very similar. Only level of service 
was significant for both blocks.  
 As presented in the literature, clinicians 
should provide combination therapy (e.g., counseling 
and medication) and offer these options to smokers 
with diabetes (Millett, 2007; Sherman, 2005). A 
combination of counseling and medication was more 
effective than counseling alone in reducing the 
prevalence of smoking among diabetics and non-
diabetics represented in this study and hence could 
reduce the risk of complications for smokers with 
diabetes who quit (Millett, 2007; MacAller et al., 
2011; Sherman, 2005; Steinberg et al., 2008). This 
study supports that diabetics do not respond 
differently to smoking cessation programs than non-
diabetics; however, smoking cessation is still crucial 
for this population as they experience by far poorer 
health outcomes that result in shorter life expectancy 
as compared to the general population (Millett et al., 
2007; Will et al., 2007).  
 
Study Limitations 
First, data was strictly self-reported and 
hence recall bias could have influenced the final 
reported information. In this study, participants might 
have over or under estimated information about their 
diabetes status, quit status, smoking cessation method 
used, and whether or not they received physician 
advice to quit. Secondly, the study time frame was 
relatively short, covering only a total 21 months 
worth of data with just one follow-up evaluation at 6 
months. Thus, longer study duration with multiple 
follow-up evaluations would potentially be beneficial 
in identifying statistically significant associations. 
Third, data were only used from one study site and 
hence this dataset may not be a true representative of 
the demographics of the entire state. For example, not 
all of the Nevada residents are smokers and not all of 
the Nevada residents who smoke actually call the 
Quitline. Additional research opportunities that will 
collect data or conduct a review of secondary data 
from multiple settings are highly encouraged.  
 
Conclusion 
 
This study was conducted to evaluate the 
effectiveness of interventions for smoking cessation 
among people with diabetes. Healthcare providers 
have an opportunity to address and assess for tobacco 
use among their diabetes patients during routine 
medical care. Healthcare visits should provide 
teachable moments when a patient’s worries and 
concerns about tobacco use are answered during their 
routine medical care (Fiore, Goplerud, & Schroeder, 
2012). Research shows that, smokers with diabetes 
are less active and often depressed as compared to 
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smokers without diabetes, and therefore this 
population requires constant monitoring and 
encouragement of their smoking cessation efforts 
(Solberg, 2004; Tonstand, 2009). In January of 2012, 
the Joint Commission's new requirements for 
addressing tobacco use in Hospital facilities were 
officially launched in the hopes of improving 
smoking cessation interventions (Fiore et al., 2012). 
The question to whether each and every hospital 
follows this rule has yet to be explored; however, 
many hospitals are making efforts in training their 
employees on how to address tobacco use and 
referring their patients to a resource such as their 
state Quitline. 
 
Therefore, this study could contribute to the 
knowledge that healthcare providers need in order to 
create and enforce policies surrounding smoking 
cessation specifically among people with chronic 
conditions such as smokers with diabetes. Findings 
from this research could help healthcare providers, 
facilities, hospitals, and organizations improve their 
routine practices, thus resulting in the reduction of 
the prevalence of smoking among persons with 
diabetes. Also, a combination of counseling and 
medication was significantly more effective than 
counseling alone and therefore, health care providers 
should emphasize this method in order to help 
smokers with diabetes quit. Overall, this study 
provides useful information pertaining to the most 
effective smoking cessation methods among smokers 
with diabetes. These changes could improve the 
quality and quantity of their lives enriching them, 
their families as well as their communities.  
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Appendices 
Appendix A 
 
Table 1 
 
Frequencies and Percentages for categorical demographic variables  
___________________________________________________________________________________________ 
    n   %   
Gender     
 Male 310  43.2  
 Female 408  56.8  
Race/Ethnicity     
 Hispanic 104  14.4  
 African American 114  15.8  
 Caucasian 476  66.1  
 Other 26  3.6  
Intent to Quit within 30 Days (from Intake)     
         Yes 656  94.1  
         No 6  .9  
         Unsure 35  5.0  
 
Physician Advice     
   Yes 109  15.1  
   No 611  84.9  
Smoking Cessation Method     
 Level II: Counseling Only 440  61.1  
 Level III: Counseling and Medication 280  38.9  
Diabetes     
 No 598  83.1  
 Yes 122  16.9  
 
Note.  Frequencies not summing to N = 720 reflect missing data. 
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Table 2 
 
Logistic regression predicting quit status from smoking cessation method, diabetes, and covariates 
    B SE Wald OR p   
Block 1       
 Level III: Counseling and Medicationa .701 .17 17.71 2.016 < .001  
 Diabetesb .205 .22 .90 1.228 .342  
Block 2       
 Level III: Counseling and Medicationa .661 .17 15.39 1.938 < .001  
 Diabetesb .175 .22 .64 1.191 .424  
 Age .008 .01 1.49 1.008 .223  
 Hispanicc .060 .24 .06 1.062 .807  
 African Americanc .240 .23 1.12 1.271 .290  
 Other Ethnicityc .025 .48 .00 1.025 .959  
 Physician Adviced -.268 .24 1.26 .765 .261  
 How important is it that you quit using tobacco? e -.001 .21 .00 .999 .997  
 
How sure are you that you will be able to quit using 
tobacco even in stressful situations? e .001 .21 .00 1.001 .996  
 
How sure are you that you will be able to quit 
tobacco, using our program? e .081 .19 .19 1.085 .660  
 How committed are you to quit using tobacco? e -.229 .18 1.64 .795 .201  
 
How confident are you that you will be able to quit 
tobacco this time? e .135 .19 .50 1.145 .481  
 
Note.  Block 1: χ2 (2) = 17.98, p < .001, Nagelkerke R2 = .035. Block 2: χ2 (12) = 23.94, p = .021, Nagelkerke R2 = 
.047. Model change: χ2 (10) = 5.96, p = .819, Nagelkerke R2 = .012. acompared to counseling only; bcompared to no 
diabetes; ccompared to Caucasian; dcompared to no physician advise; csomewhat/very compared to not at all/not 
very/not sure.  
 
 
 
 
 
 
 
 
 
 
